Skip to main content

Current Funding Announcements

See below

Patient-Centered Outcomes Research Institute (PCORI): PCORI Funding Announcements 2021

PCORI funds research that offers patients and caregivers the information they need to make 
important healthcare decisions. PCORI’s “National Priorities and Research Agenda” can be found 
support/national-priorities-and-research-agenda. PCORI pays particular attention to conditions that 
affect large numbers of people across a range of populations; conditions that place a heavy burden 
on individuals, families, specific populations, and society; and rare diseases, which are difficult 
to study.
On 9/7/21, PCORI announced a funding cycle that includes multiple PCORI Funding Announcements 
(PFAs) on broad and targeted research topics, large clinical trials, and methodology studies. They 
include:
•    Broad PFAs seek investigator-initiated applications for patient-centered comparative clinical 
effectiveness research (CER) aligned with PCORI research priorities: addressing disparities; 
assessment of prevention, diagnosis, and treatment options; communication and dissemination 
research; and improving health systems.
•    Improving Methods PFA aims to fund studies that address high-priority methodological gaps in 
patient-centered outcomes research and CER. Programmatic priorities include methods to improve the 
use of artificial intelligence and machine learning in clinical research, enhance study design, and 
support data research networks.
•    Targeted Research PFAs seek CER projects on specific topics: healthy aging (maintaining 
function and independence, facilitating chronic disease management, supporting individuals with 
significant functional impairment, reducing caregiving burden and improving quality of life), 
osteoporotic fractures, and migraine prevention.
•    Phased Large Clinical Trials accepting Letters of Intent for research to fund large, 
innovative clinical trials in CER pursuing research questions focused on patient-centered outcomes 
on high-burden, high-impact health topics in real-world clinical settings.
 
 
Letters of Intent for all the above PFAs are due October 5, 2021.
Additional information is available in the newly published blog
 

DoD Traumatic Brain Injury and Psychological Health

W81XWH-21-TBIPHRP: DoD Traumatic Brain Injury and Psychological Health

 

Description: The FY21 Defense Appropriations Act provides funding to the Department of Defense 
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) to support
traumatic brain injury (TBI) and psychological health research 
(https://cdmrp.army.mil/tbiphrp/default). The managing agent for the anticipated program 
announcements/funding opportunities is the Congressionally Directed Medical Research Programs 
(CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
The TBIPHRP vision is to optimize psychological health and reduce or eliminate the effects of TBI 
and traumatic stress. The program seeks to fund research to understand, prevent, and treat TBI and 
psychological health conditions that accelerates solutions to improve the health, wellbeing, and 
healthcare of Service Members, Veterans, military beneficiaries, and the American public.
 
Applications submitted to the FY21 TBIPHRP must address identified Focus Areas (Understand, 
Prevent, Treat), not all of which will be applicable to every award mechanism. Research of interest 
includes:
      •     [Understand] Computational models from clinical data to forecast the long-term and/or late 
     effects of brain exposures, such as TBI, critical traumatic events, and co-occurring conditions.
     •     [Prevent] Identification and validation of biomarkers or other objective markers for 
     diagnosis, prognosis, or monitoring of psychological health conditions/brain injuries, repetitive 
     exposures, and associated sequelae (e.g., chronic migraine, dizziness, neurocognitive symptoms, 
     sleep, post-traumatic headache).
     •     [Prevent] Development of injury thresholds and exposure standard.
     •     [Treat] Interventions focused on sensory and locomotor dysfunction after brain injury.

W81XWH-21-TBIPHRP-CRDA: Clinical Research Development Award

     •     Pre-Application Submission Deadline: September 8, 2021
     •     Application Submission Deadline: September 30, 2021
     •     Maximum period of performance 18 months; max funding $300,000
 
W81XWH-21-TBIPHRP-TRA: Translational Research Award
     •     Pre-Application Submission Deadline: September 15, 2021
     •     Application Submission Deadline: December 16, 2021
     •     Maximum period of performance 4 years; max funding $1.5M
 
W81XWH-21-TBIPHRP-IIRA: Investigator-Initiated Research Award
     •     Pre-Application Submission Deadline: September 8, 2021
     •     Application Submission Deadline: September 30, 2021
     •     Maximum period of performance 3 years; max funding $750,000
 
W81XWH-21-TBIPHRP-IDA: Idea Development Award
     •     Pre-Application Submission Deadline: September 8, 2021
     •     Application Submission Deadline: September 30, 2021
     •     Maximum period of performance 2 years; max funding $300,000

W81XWH-21-S-TBIPH2: Focused Program Award

     •     Pre-Proposal/Pre-Application Submission Deadline: September 15, 2021
     •     Proposal/Application Submission Deadline: December 16, 2021
     •     Maximum period of performance 4 years; max funding $8M

W81XWH-21-S-TBIPH1: Clinical Trial Award

     •     Pre-Proposal/Pre-Application Submission Deadline: September 15, 2021
     •     Proposal/Application Submission Deadline: December 16, 2021
     •     Maximum period of performance 3-4 years; max funding $750,000 (Level 1) - $6M (Level 3)
 
Full announcements and additional information available at: 
 

Combat Readiness – Medical Research Program Rapid Development and Translational Research Award

W81XWH-21-S-CRRP: Combat Readiness – Medical Research Program Rapid
Development and Translational Research Award
 
Description: The CRRP focuses on forward-deployable solutions that can promptly address life- 
threatening injuries, medical threats, and treatments for Warfighters in current and future 
battlefield settings. The CRRP vision is to deliver high-impact medical solutions in diverse 
operational settings and closer to the point of injury to increase survivability and Warfighter 
readiness. The program seeks to develop innovative solutions to increase medical readiness, 
mitigate fatalities, optimally treat life-threatening injuries, and promote positive long-term 
outcomes. The program also considers how chronic disorders typically associated with pre- 
deployment readiness (e.g., sleep, gastrointestinal conditions, posttraumatic arthritis) may 
influence the delivery of care in deployed environments and contribute to injury susceptibility and 
recovery. Innovations developed by CRRP-supported research may be applied proactively as a way to 
establish medical readiness ahead of deployment, in operational settings at the point of injury, 
during periods of prolonged care, or during transport/en route between roles of care.
Focus Areas broadly describe current priorities to improve readiness for delivering frontline care 
in combat situations and for delivering medical damage control capability, assets, and life- saving 
interventions during prolonged and en route care in austere and combat environments, including the 
acute and early management of combat-related trauma at the point of injury.
They include solutions to enhance combat care delivery throughout the far-forward environment, such 
as:
     o Telemedicine solutions that enable medical capabilities at far-forward battlespace locations 
         worldwide
     o Solutions for the assessment of mild traumatic brain injury, to include portable devices
 
Awards funded under this mechanism may propose a base award with a potential option year (not 
required) to be considered for funding with a future appropriation, if available.
 
Pre-app due: 31 August 2021
Invitations for Full Application Submission: 15 October 2021
Full app due: 1 December 2021
Max Period of Performance: 2 years (3 years with option)
Budget: CDMRP expects to allot approximately $7.2M to fund approximately four 
proposals/applications.
 

American Hearing Research Foundation Discovery Grants

American Hearing Research Foundation: Hearing and Balance Disorders of the
Inner Ear and Related Topics

Description

AHRF Discovery Grants (formerly called Regular Grants) funds studies that investigate various 
aspects of hearing and balance disorders related to the inner ear. AHRF typically funds six to ten 
Discovery Grants each year. Priority is given to investigators early in their careers who need seed 
funds to generate results and data that can be used to support applications for larger grants 
(i.e., NIH grants) in the future.
The Birtman Grant may be awarded for exceptional scientific investigation when AHRF identifies a 
study that shows outstanding promise.
Both basic and clinical studies may be proposed that investigate aspects of the auditory and 
vestibular systems including but not limited to:
 
•    genetics
•    neurotology
•    anatomy
•    auditory processing
•    molecular and cellular biology
•    therapeutic studies
•    investigations of current or experimental devices (i.e., cochlear implants)
 
AHRF donors have given special support for research that explores Meniere’s disease (mechanisms, 
causes, or treatments) and the causes or mechanisms of sudden hearing loss. Proposals that address 
these areas of interest will receive special consideration during the review process.
 
Applicants must hold an MD, PhD, AuD, or equivalent degree(s) and be associated with a university 
or hospital in the United States.
Next deadline: August 16, 2021
Maximum Project Period: 1 year (1/1/2022 – 12/31/2022)
Maximum Amount: $50,000 (Discover Grant), $75,000 (Birtman Grant)

 

Additional Information: https://www.american-hearing.org/research-grants/grants-we-offer/

https://www.american-hearing.org/research-grants/grant-process/

 

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)

RFA-DC-22-001: NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)
NIH - National Institute on Aging (NIA) and National Institute on Deafness and Other Communication 
Disorders (NIDCD)
Description: This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic 
scientists, clinicians and clinical scientists to jointly initiate and conduct translational 
research projects which translate basic research findings into clinical tools for better human 
health. The scope of this FOA includes a range of activities to encourage translation of basic 
research findings which will impact the diagnosis, treatment and prevention of communication 
disorders.  Connection to the clinical condition must be clearly established and the outcomes of 
the grant must have practical clinical impact.


Possible goals include, but are not limited to:

 
•     Biochemical, electrophysiological and behavioral assays to enhance diagnostic capabilities.
•     Pharmacology, toxicity, and pharmacokinetic for candidate therapeutics that have demonstrated 
potential for the treatment of communication disorders.
•     Preclinical animal research for dosage studies and toxicity when a subsequent Phase I/II 
clinical trial is planned.
•     Translation of new tools and techniques for better diagnostics or therapeutics, including but 
not limited to, neuroprosthetic devices, drug delivery devices, neuro-electrical stimulators and 
recording devices.
•     Translation of laboratory-based screening tests, including biomarkers into improved ways to 
identify individuals at risk for a communication disorder to allow for early intervention.
•     Translation of published basic research findings into new clinical tools to better target the 
treatment to the individual patient and to better predict patient response or prognosis.
•     Translation of discoveries from biological, psychological, social sciences and other related 
areas into innovative prevention and treatment paradigms and processes.
•     Modification of laboratory measures of function or laboratory treatment protocols for use in 
clinical settings.
 
Open Date (Earliest Submission Date): September 17, 2021
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): October 20, 2021; June 20, 2022; February 22, 2023; October 18,
2023; June 20, 2024
Maximum Project Period: 5 years
Maximum Amount: NIDCD anticipates funding an estimated 2-3 awards in fiscal year 2022 for a total 
of $1,500,000.
 

Open/Active DoD Broad Agency Announcements

U.S. Army Medical Research and Development Command (USAMRDC) - W81XWH18SBAA1: This BAA is open through September 30, 2022. USAMRDC funds a broad range of extramural research programs through contracts, grants, or cooperative agreements. Proposals can be submitted through the USAMRDC Broad Agency Announcement (BAA) or through special USAMRDC BAA Announcements, which are open for limited timeframes. Additional information, the USAMRDC Broad Agency Announcement, and open special USAMRDC BAA Announcements can be obtained at:  https://www.usamraa.army.mil/Pages/BAA.aspx and https://www.grants.gov/web/grants/view-opportunity.html?oppId=297726

U.S. Air Force/AFRL - 711 HPW BAA: The Airman Readiness Medical Research (ARMR) Hybrid Broad Area Announcement (BAA) was released May 1, 2020, and will remain open for 72 months for medical research to optimize the warfighter by enabling, enhancing, restoring, and sustaining the Airman to more effectively execute the Air Force mission. This medical research objective aims to: (1) ensure medical availability of Airmen by analyzing attributes (sensory, behavioral, physiologic) and operational environments (chemical, physical, psychological, biological, radiological stressors) to drive optimal performance of Airmen engaged in high-demand, high-impact mission tasks (2) investigate how the flight environment affects the process of life, the ability to maintain homeostasis, and the risk for injury or secondary insult, seeking to ameliorate these stressors to optimize Airman health and performance.

             See:  https://beta.sam.gov/opp/31a536d407cd4d519fc89ffd3366cbb3/view?keywords=AirmanReadinessMedicalResearch(ARMR)&sort=relevance&index=&is_active=true&page=1

      

U.S. Air Force/AFRL - BAA-AFRL-RQKHC-2016-0009 Aerospace Medicine, Clinical Research, Human Performance Research, and Expeditionary Medicine: This BAA will remain open for seventy-two (72) months with calls being released throughout the seventy-two (72) month period of performance.  The Air Force Research Laboratory (AFRL) 711 Human Performance Wing in the School of Aerospace Medicine and Human Systems Integration Directorate solicits innovative research proposals in the following five research areas.
1. Force Health Protection – Focus on research to prevent injury and illness and the early recognition or detection of emerging threats. 2. EN Route Care –Continuum of care during transport of patients from point of injury to point of definitive care.
3. Operational Medicine (OM) – Air Force Medical Service (AFMS) sponsored OM encompasses interest in definitive diagnosis, care, and treatment in-garrison, to ensure the highest quality of healthcare for active duty members and their families.
4. Expeditionary Medicine - Improving expeditionary medical care during contingency operations including medical countermeasures against combat and operational stressors to maximize warrior health, performance, and well-being.
5. Human Performance and Systems Integration - Maximizing operational human performance for a fit and healthy force.

             See: https://beta.sam.gov/opp/4eebfe8f580a41e8a32ba4eae5920342/view?keywords=AerospaceMedicine,ClinicalResearch,HumanPerformanceResearch,andExpeditionaryMedicine&sort=-relevance&index=&is_active=true&page=1

 

U.S. Military Academy Broad Agency Announcement - W911NF-20-S-0008: This BAA was released April 1, 2020, and is open until March 31, 2025. It seeks proposals for cutting- edge innovative research that could produce discoveries with significant impact to enable new and improved Army technologies and related operational capabilities in the areas of socio-cultural; information technology; ballistics, weapons and protections; energy and sustainability; materials, measurements, and facilities; unmanned systems and space; human support systems; and artificial intelligence, machine learning, and quantum technologies. The human support systems focus includes biomechanical engineering to enhance soldier readiness (human performance optimization, injury prediction/prevention, physical and cognitive augmentation, Return-to-Duty metrics, functional influence of prosthetics/exoskeletal devices) and wearable technologies and sensors to inform performance decisions (e.g., monitoring/assessment, injury prevention, recovery times). 

              See:  Military Academy BAA

NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders

NOT-DC-20-008: NIDCD is Interested in Supporting Research on the Impact of

COVID-19 on Mission Specific Sensory and Communication Disorders

 

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other

Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOT-DC20-008.html)

 

NIDCD invites applications for research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech, and language. Given the early stage of COVID19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models. Areas of research encouraged through this NOSI include, but are not limited to:

 

  • Short- and long-term effects of COVID-19 on the auditory, vestibular, or olfactory systems
  • The prevalence, onset, and resolution of acquired deficits (i.e. HBTSVSL) among patients

    with COVID-19 across the lifespan and in association with various underlying genetic predispositions and health conditions

  • Potential ototoxicity from therapeutics or vaccination related to COVID-19
  • Worsening of communicative function because of physical distancing, sheltering in place,

    and wearing of protective personal equipment during mitigation of this infectious pandemic

  • Telehealth service delivery to individuals with communication disorders
  • Multidisciplinary collaborative teams including clinicians, basic biologists, geneticists,
    quantitative scientist, epidemiologists, or other researchers to study COVID-19 related
    human conditions and behaviors, bioethical considerations, health-service delivery,
    health services in low-resource areas, and health disparities within NIDCD mission areas

 

This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022. Submit applications for this initiative using one of the following funding opportunity announcements or any reissues of these announcement through the expiration date of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-196, PA-20-195, PA-20-194, PA-19-270, PA-19-271, PA-19-273, PA-19-272.

 

For funding consideration, applicants must include “NOT-DC-20-008” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

 

Scientific/Research Contact:

 

Bracie Watson, Jr. Ph.D.

NIDCD/Division of Scientific Programs

Telephone: 301-402-3458

Email: watsonb@nidcd.nih.gov

Improving Outcomes for Disorders of Human Communication Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other Communication Disorders (NIDCD)

NOT-DC-20-007: Improving Outcomes for Disorders of Human Communication

Notice of Special Interest (NOSI) issued by the National Institute on Deafness and Other

Communication Disorders (NIDCD) (see: https://grants.nih.gov/grants/guide/notice-files/NOTDC-20-007.html)


This NOSI seeks to encourage effectiveness and health services research for improved

outcomes in the prevention and treatment of disorders of hearing, balance, smell, taste, voice,

speech, and language.

 

NIDCD effectiveness research seeks to measure, evaluate, and/or improve patient-centered

outcomes following intervention for communication disorders. Effectiveness research seeks to

determine to what degree an intervention works in patients/populations in general, real-world

settings, such as in diverse populations and diverse provider and clinical practice settings.

 

Health Services Research examines the impact of the organization, financing, and management

of health care services on the delivery, quality, cost, access to and outcomes of such services,

including demographic, social, economic, and health system factors as they relate to providing

preventive, screening, diagnostic, treatment and rehabilitative services and patient outcomes

of care. Research may focus on any/all of the different factors that impact access, utilization,

and quality as related to outcomes of health care services.

 

Applicants are encouraged to create collaborative teams which may include clinical experts not

only in the traditional NIDCD mission areas, but also in other medical specialties and health care

professions as well as experts in sociology, health services, health outcomes, economics,

biostatistics, public health, health care financing and organization, survey research,

psychometrics, epidemiology, and evaluation.

 

This notice applies to due dates on or after June 16, 2020 and subsequent receipt dates

through January 10 2022. Submit applications for this initiative using one of the following

funding opportunity announcements (FOAs) or any reissues of these announcement through

the expiration date of this notice: PA-18-334, PA-20-185, PA-20-184, PA-20-195, PA-20-194,

PAR-18-340, PA-19-272, PA-19-270, PA-19-273, PA-19-271.

 

For funding consideration, applicants must include “NOT-DC-20-007” (without quotation marks)

in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this

information in box 4B will not be considered for this initiative. For due dates after May 25,

2020, applicants must use "FORMS-F".

 

Scientific/Research Contact:

 

Kelly King, Au.D, Ph.D.

NIDCD/Division of Scientific Programs

Telephone: 301-402-3458

Email: kingke@nidcd.nih.gov

Army Research Office Broad Agency Announcement for Fundamental Research

Announcement: Funding

Title:  ARMY RESEARCH OFFICE BROAD AGENCY ANNOUNCEMENT FOR FUNDAMENTAL RESEARCH

Type/Mechanism: Grant
Funding Opportunity Number: 
W911NF-17-S-0002-04

Application Open:  1 April, 2017 – 31 March 2022

Notes:  (See below for additional info)

Description: ARO is focused exclusively on extramural basic research, and is responsible for the vast majority of ARL’s extramural research programs and funding. Competencies are structured to create discovery, innovation, and transition of technologies leading to Power Projection Superiority, Information Supremacy, Lethality and Protection Superiority, and Soldier Performance Augmentation for Strategic Land Power Dominance. Proposals are expected to be for cutting-edge innovative research that could produce discoveries that would have a significant impact on enabling new and improved Army operational capabilities and related technologies. Specific research areas and topics of interest should be viewed as suggestive, rather than limiting. ARO is always interested in considering new innovative research concepts of relevance to the Army. Additional information about ARO areas of interest can be found on the ARL website:

http://www.arl.army.mil/www/default.cfm?page=29.

Research areas of interest include

·        Life Sciences (Neurophysiology of Cognition/Multisensory Synthesis)

·        Intelligent Systems for Improved Decision Making (sensing, perception, situation awareness)

·        Biomathematics (modeling sensory processing, disease processes)

·        International Opportunities: Human Dimension, Big Data

This Funding Opportunity Announcement is a BAA. It is continuously open for a 5-year period, from 01 April 2017 closing 31 March 2022. Proposals will be considered until and including the closing date of this announcement.

There are no specific funding restrictions associated with this BAA. The proposed duration for which support is requested should be consistent with the nature and complexity of the proposed activity.

For more information, https://www.grants.gov/web/grants/view-opportunity.html?oppId=292877

NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)

Announcement: Grant
Title:  NIDCD Clinical Research Center Grant (P50/Clinical Trial Optional)
Award Organization: NICD
Type/Mechanism: Grant
Funding Opportunity Number: PAR-19-137
Award Amount: $1.5M/year 
Pre-proposals Due:  7 Jan, 2019
Full App Due: February 6, 2019; June 6, 2019; October 4, 2019; February 6, 2020; June 8, 2020; October 6, 2020; February 8, 2021; June 6, 2021; October 6, 2021


Notes: 
Description: The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders.  For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, treatment, management or epidemiology of a disease or disorder of hearing, balance, smell, taste, voice, speech, or language.

Applications may propose a clinical trial but are not required (optional).  

Proposed research must meet 4 essential criteria:

1.  Must be clinical as defined above.
2.  Must have a well-defined central unifying theme consisting of three or more research projects with 1 or more supporting cores as appropriate; one core must be an administrative core.
3.  Each project must be unambiguously related to the central unifying theme. Synergistic and substantial interactions among the projects should be evident.
4.  Must provide multidisciplinary approaches to the central theme, defined as having research projects representing different disciplines, approaches and expertise. 

Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-137.html

 

broad agency announcement (baa) for extramural biomedical research and development

Announcement: Grant
Title:  BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development
Award Organization: USSOCOM 
Type/Mechanism: Grant
Funding Opportunity Number: W81XWH-18-S-SOC1
Web Site: DoD : https://www.grants.gov/web/grants/view-opportunity.html?oppId=307754 
Expected Number of Awards: 2
Period of Performance:  2 years
Open App: 1 Aug 2018
Close App: 31 Jul 2023
Description: A primary emphasis of the USSOCOM Biomedical, Human Performance, and Canine Research Program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care (PFC), human performance optimization, and canine medicine/performance. Special Operations Forces (SOF) medical personnel place a premium on medical equipment that is small, lightweight, ruggedized, modular, multi-use, and designed for operation in extreme environments. The equipment must be easy to use, require minimum maintenance, and have low power consumption. Drugs and biologics should not require refrigeration or other special handling. All materiel and related techniques must be simple and effective, and easily modified for commercialization. 

Research areas of interest include:

• Canine Medicine: 
o Sensory Optimization and Protection: The proposed project must develop research oriented toward innovative methods that enhance or conserve SOF canine olfactory, visual, and/or auditory performance during combat operations.

Max Funding: Most projects are anticipated to have a total cost at or below $700,000 (including indirect costs). Projects that have a total cost higher than $700,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $1,500,000 (including Indirect costs). No budget will be approved by the Government exceeding $1,500,000 (including indirect costs).

Research Interests of the Air Force Office of Scientific Research

Announcement: BAA-AFRL-AFOSR-2016-0007
Award Organization: Air Force Office of Scientific Research
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD: http://www.grants.gov/web/grants/view-opportunity.html?oppId=285269
Award Amount: $200,000 - $400,000 encouraged; $7.5M max
PoP: 5 years
Restrictions: None
Rolling Annual Programs: Open until Superseded
Pre-Application Due: Open until superseded
Full App Due: Open until superseded
Notes: For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources.

DOD USAMRMC FY18-FY22 Broad agency announcement for extramural medical research

Announcement: W81XWH18SBAA1
Award Organization: U.S. Army Medical Research and Material Commnad's
Type/Mechanism: Grants Notice
Activity Code: USC, Title 10, Section 2358
Web Site: https://www.grants.gov/web/grants/search-grants.html?keywords=W81XWH18SBAA1
Award Amount:  
PoP: 4 years 
Restrictions: 
Rolling Annual Programs:
Pre-Application Due: Oct 1, 2017
Full Application Due :  September 30, 2022, 11:59 p.m. ET
Notes: Clinical and Rehabilitative Medicine Research Program focus on the innovations required to reset our wounded Service members, both in terms of duty performance and quality of life. Innovations developed from CRMRP-supported research efforts are expected to improve restorative treatments and rehabilitative care to maximize function for return to duty (RTD) or civilian life. 
The CRMRP focuses its efforts on the following research areas: neuromusculoskeletal injury (including limb trauma and amputation), sensory systems impairment (including hearing, balance, tinnitus, and vision), acute and chronic pain, and regenerative medicine.

Quick Fact

#10

Some of the noisiest occupations in the United States include agriculture, mining, plumbing, and the military.

About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.